Young Kids With Allergic Asthma can use Omalizumab safly

According to data released this weekend to approve the safty and tolerability of Omalizumab in childern with allergic asthma.

childhood asthma

allergic asthma that is moderate or severe therapy by steroids inhalation are by far the most commonly used drugs in this setting and are usually effectivethe

the new study made on 926 children, ages 6 to 12, who had been randomized in a 2:1 design in two separate studies to omalizumab or placebo, 75-375 mg subcutaneously, every 2 or every 4 weeks. One study lasted 28 weeks, and the other study lasted 52 weeks

the results show that omalizumab’s safety profile in 6- to 12- year olds is similar to that in older children and adults in efficacy of omalizumab in young children whose allergic asthma is not satisfactorily controlled with current therapy